Skip to main content

Coronary Artery Bypass Graft Market is Flattened To Increase at a Crispy CAGR of 6% During Forecast to 2022

Market Potential and Pitfalls:
The primary reasons because of which people are prone to cardiovascular ailments that require CABG in order to be cured include anxiety, deskbound lifestyle, high consumption of junk food, and stress. Due to the rise in cardiovascular ailments, the market for coronary artery bypass grafting is also rising. Other factors responsible for the growth of this market include changing lifestyle, increase in patient’s awareness of this ailment, and surgeries & therapies related to CABG.
Market Synopsis:
Market Research Future (MRFR) postulates that the global Coronary Artery Bypass Graft Market Profiles is slated to garner USD 116 million, grabbing a CAGR of 6.0% during the forecast period (2016-2022). The surging incidences of cardiovascular disease due to changing lifestyle is estimated to favor the market growth worldwide. Coronary artery bypass grafting (CABG) is referred to as a type of bypass surgery used to create new routes for the blood to flow into the heart. CABG is generally used in patients suffering from severe coronary heart disease. CABG is caused due to anxiety, deskbound lifestyle, high consumption of junk food, and stress. Observing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. The primary reasons because of which people are prone to cardiovascular ailments that require CABG in order to be cured include anxiety, deskbound lifestyle, high consumption of junk food, and stress. Due to the rise in cardiovascular ailments, the market for coronary artery bypass grafting is also rising. Other factors responsible for the growth of this market include changing lifestyle,
increase in patient’s awareness of this ailment, and surgeries & therapies related to
CABG.
Competitive Dashboard:
  • Genesee BioMedical
  • MAQUET Holding B.V. & Co. KG
  • Edwards Lifesciences Corporatio
  • Neograft Inc
  • Sorin Group
  • Dextera Surgical Inc
  • Terumo Cardiovascular Systems Corporation
  • VasoPrep Surgical
  • Hancock Jaffe Laboratories Inc
  • NOVADAQ Technologies Inc
Global Coronary Artery Bypass Graft Market: Segmental Analysis:
  • The global coronary artery bypass graft market has been segmented on the basis of type, procedure, and end-users.
  • By mode of type, the global coronary artery bypass graft market has been segmented into on-pump, off-pump, endoscopic vein harvesting, minimally invasive direct CABG, and others. Among these, the off-pump segment is estimated to gain significant prominence in the long run due to the advantages it offers. The reduced inflammatory response, minimal blood loss, lower postoperative complications, mortality rate, and lower morbidity drive the segment globally.
  • By mode of procedure, the global coronary artery bypass graft market has been segmented into double CABG surgery, single CABG surgery, quadruple CABG surgery, triple CABG surgery, and others.
  • By mode of end-users, the global coronary artery bypass graft market has been segmented into cardiology clinics, hospitals, research institutes, and others.
Regional Insights:
Globally North America is leading the global coronary artery bypass graft market which is further expected to grow with approximately 6.4% CAGR during the forecast period (2016-2022). Moreover, factors such as the high per capita healthcare spending and the growing population in the region are expected to spur the market growth in the region.
Markets in the U.S. and Canada led by the rising number of bypass surgeries and the growing prevalence of coronary diseases lead the regional market. Furthermore, the rapid uptake of advanced technologies and devices in the surgical process is also an essential driver of the market.
The European region witnessing the increasing number of coronary artery bypass procedures accounts for the second-largest market, globally. Factors such as increasing healthcare expenditures and spreading awareness of CABG procedures impact the market growth in the region.  Also, the resurging economy is playing a vital role in increasing the market value in the region.
Furthermore, factors such as the availability of specialty care services in hospitals & tertiary care centers, increasing demand for the treatment options of cardiovascular diseases, and rising prevalence of cardiovascular diseases escalate the market growth in the region.
Moreover, factors positively impacting the growth of the regional market include the growing emphasis on coronary artery bypass procedures and increasing geriatric population with chronic diseases such as diabetes & obesity which increase the risk for heart disease, and rising prevalence of cardiovascular diseases.
.

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...